Literature DB >> 23632624

Pointwise confidence intervals for a survival distribution with small samples or heavy censoring.

Michael P Fay1, Erica H Brittain, Michael A Proschan.   

Abstract

We propose a beta product confidence procedure (BPCP) that is a non-parametric confidence procedure for the survival curve at a fixed time for right-censored data assuming independent censoring. In such situations, the Kaplan-Meier estimator is typically used with an asymptotic confidence interval (CI) that can have coverage problems when the number of observed failures is not large, and/or when testing the latter parts of the curve where there are few remaining subjects at risk. The BPCP guarantees central coverage (i.e. ensures that both one-sided error rates are no more than half of the total nominal rate) when there is no censoring (in which case it reduces to the Clopper-Pearson interval) or when there is progressive type II censoring (i.e. when censoring only occurs immediately after failures on fixed proportions of the remaining individuals). For general independent censoring, simulations show that the BPCP maintains central coverage in many situations where competing methods can have very substantial error rate inflation for the lower limit. The BPCP gives asymptotically correct coverage and is asymptotically equivalent to the CI on the Kaplan-Meier estimator using Greenwood's variance. The BPCP may be inverted to create confidence procedures for a quantile of the underlying survival distribution. Because the BPCP is easy to implement, offers protection in settings when other methods fail, and essentially matches other methods when they succeed, it should be the method of choice.

Entities:  

Keywords:  Clopper–Pearson confidence interval; Exact confidence interval; Kaplan–Meierestimator; Median survival; Non-parametric methods; Survival analysis

Mesh:

Substances:

Year:  2013        PMID: 23632624      PMCID: PMC3769999          DOI: 10.1093/biostatistics/kxt016

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  6 in total

1.  Symmetric tests and confidence intervals for survival probabilities and quantiles of censored survival data.

Authors:  S Barber; C Jennison
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  A simple hybrid variance estimator for the Kaplan-Meier survival function.

Authors:  Craig B Borkowf
Journal:  Stat Med       Date:  2005-03-30       Impact factor: 2.373

3.  High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

Authors:  Richard A Nash; Peter A McSweeney; Leslie J Crofford; Muneer Abidi; Chien-Shing Chen; J David Godwin; Theodore A Gooley; Leona Holmberg; Gretchen Henstorf; C Fred LeMaistre; Maureen D Mayes; Kevin T McDonagh; Bernadette McLaughlin; Jerry A Molitor; J Lee Nelson; Howard Shulman; Rainer Storb; Federico Viganego; Mark H Wener; James R Seibold; Keith M Sullivan; Daniel E Furst
Journal:  Blood       Date:  2007-04-23       Impact factor: 22.113

4.  Accurate confidence limits for quantiles under random censoring.

Authors:  R L Strawderman; M I Parzen; M T Wells
Journal:  Biometrics       Date:  1997-12       Impact factor: 2.571

5.  Effective sample sizes for confidence intervals for survival probabilities.

Authors:  F J Dorey; E L Korn
Journal:  Stat Med       Date:  1987-09       Impact factor: 2.373

6.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  6 in total
  8 in total

1.  Confidence intervals for the cumulative incidence function via constrained NPMLE.

Authors:  Paul Blanche
Journal:  Lifetime Data Anal       Date:  2018-12-11       Impact factor: 1.588

2.  Statistical description for survival data.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2016-10

3.  Combining one-sample confidence procedures for inference in the two-sample case.

Authors:  Michael P Fay; Michael A Proschan; Erica Brittain
Journal:  Biometrics       Date:  2014-10-01       Impact factor: 2.571

Review 4.  Finite sample pointwise confidence intervals for a survival distribution with right-censored data.

Authors:  Michael P Fay; Erica H Brittain
Journal:  Stat Med       Date:  2016-02-18       Impact factor: 2.373

Review 5.  Treating Cancer as an Invasive Species.

Authors:  Javad Noorbakhsh; Zi-Ming Zhao; James C Russell; Jeffrey H Chuang
Journal:  Mol Cancer Res       Date:  2019-09-16       Impact factor: 5.852

6.  Intensity-modulated radiotherapy in the treatment of locoregionally advanced head and neck cancer: implementation and outcomes in a New Zealand community hospital.

Authors:  Christopher N Rumley; Nikolay Nedev; Katrina Sharples; Jeat Lee; David S Lamb
Journal:  J Med Radiat Sci       Date:  2016-06-21

7.  A note on the determination of non-inferiority margins with application in oncology clinical trials.

Authors:  Binbing Yu; Harry Yang; Antony Sabin
Journal:  Contemp Clin Trials Commun       Date:  2019-09-23

8.  Exposure-response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimus.

Authors:  Thomas Dumortier; Günter Heimann; Martin Fink
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.